Device Trial Radar · NCT03767842
Volumetric Impedance to Guide Stroke Response
Last checked: Nov 21, 2026Latest source record: Dec 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
316
Planned (sponsor's estimate)
Start
Jul 18, 2018
Primary completion
Mar 31, 2019
Study completion Mar 31, 2019
Sponsor
- Lead sponsor
- Cerebrotech Medical Systems, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 7, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
Assess the ability of the Visor System to detect hemispheric bioimpedance asymmetry
Conditions
- Stroke, Acute
Interventions
Visor SystemDevice
Subjects are monitored one time with the Visor System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hemispheric bioimpedance asymmetry sensitivity and specificityTime frame: At the time of device monitoring - day 0
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Buffalo Neurosurgery
Buffalo, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.